Doxa AB (publ) (DOXA.ST) Research

Doxa AB (publ) functions as a worldwide dental enterprise, focusing on the innovation, production, and distribution of bioceramic dental solutions, which are prominently marketed under its Ceramir brand. Its product line features Crown & Bridge, a specialized dental adhesive engineered for the durable securing of prosthetic crowns and bridges. The company, headquartered in Uppsala, Sweden, began its operations in 1987.

Market snapshot

Symbol
DOXA.ST
Price
$0.38
Day change
-0.91%
Market cap
$491.1M
P/E ratio
-1.55x
52-week range
0.348-0.576
Sector
Healthcare
Industry
Medical - Instruments & Supplies

Peer companies

  • ADDvise Group AB (publ) (ADDV-B.ST)
  • Bactiguard Holding AB (publ) (BACTI-B.ST)
  • Cantargia AB (publ) (CANTA.ST)
  • Corline Biomedical AB (CLBIO.ST)
  • Enzymatica AB (publ) (ENZY.ST)
  • FluoGuide A/S (FLUO.ST)
  • Infant Bacterial Therapeutics AB (publ) (IBT-B.ST)
  • Moberg Pharma AB (publ) (MOB.ST)

Open Doxa AB (publ) (DOXA.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.